Long-Term Ambrisentan Therapy for the Treatment of Pulmonary Arterial Hypertension
Study Question: What is the 2-year safety and efficacy of ambrisentan, a selective endothelin type A receptor antagonist, in patients with pulmonary arterial hypertension (PAH)?
Australians at risk of pulmonary hypertension
Australians could be at risk of pulmonary hypertension because they are dismissing their symptoms for less serious conditions.
Team 'tries' to raise PH awareness - AUSTRALIA
A Redland Bay couple who lost their six-year-old son to Pulmonary Hypertension (PH) five months ago are "over the moon" they helped raise awareness of the deadly disease while participating in the Gatorade Tri-Series at Raby Bay.
Research shows herbal formula helps in heart and lung disease
Pulmonary hypertension which can lead to congestive heart failure may be a thing of the past according to new research. On November 3rd the American Heart Association journal Circulation, published findings by Dr.
Key protein behind pulmonary arterial hypertension identified.
n a groundbreaking discovery, researchers at the Unversity of California, San Diego, have identified a key protein that promotes the development of pulmonary arterial hypertension in humans and mice.
Sutton pensioner still going strong 21 years after heart and lungs transplant (UK)
A pensioner has defied the odds to live over two decades after a heart and lungs transplant.
Pulmonary Arterial Hypertension Reversed In Mouse Models
ScienceDaily (Oct. 26, 2009) — Researchers at the University of California, San Diego, have identified a key protein that promotes the development of pulmonary arterial hypertension in humans and mice.
Actelion Launches Increased Strength Formulation of Ventavis (Iloprost) for PH
Actelion Launches Increased Strength Formulation of Ventavis (Iloprost) for
Pulmonary Arterial Hypertension in the United States SOUTH SAN FRANCISCO, Calif., Sept. 1 /PRNewswire/ -- Actelion Pharmaceuticals US, Inc., today announced the first commercial sales of a new 20 microgram per milliliter (mcg/mL) formulation of Ventavis(R), for the treatment of New York
Pulmonary Hypertension takes young life-The McGrath Family - AUSTRALIA
The day before Mother's Day this year, Redland Bay mother Vivienne McGrath lost her six-year-old son Alex to Pulmonary Hypertension (PH).
PH is a rare, life-threatening lung disease where the sufferer's blood pressure in the arteries of their lungs elevates.
This places stress on the heart and reduces the amount of oxygen that is able to reach tissues of the body.